Nimisha Srivastava – författare

Polymer Nanofiber Applications in Cancer Wound Healing: Advances, Challenges, and Future Directions explores the use of nanoscale polymeric fibers for targeted cancer therapy and wound healing. This book addresses the need for therapeutic platforms that deliver treatment directly to tumor sites, minimizing the adverse effects on healthy tissues. It covers advances in nanofiber and biopolymer membrane development for applications such as transdermal delivery, skin regeneration, and tissue engineering, while examining the challenges and potential advancements in localized cancer treatment and wound healing.Polymer Nanofiber Applications in Cancer Wound Healing: Advances, Challenges, and Future Directions is of interest to researchers and academics in the fields of materials science, materials chemistry, pharmaceutical sciences, and cancer research.Details the characteristics, properties, and processing of polymer nanofiber biomaterials for cancer wound healing and repairReviews traditional and novel treatments in cancer therapy, including topical therapeutics and personalized medicinesExplores the use of AI in nanofiber technologyAssesses clinical trials and patents for polymer nanofiber-based cancer treatments, as well as production and commercialization challenges

This book provides concepts, procedures, guidelines, and regulatory affairs in drug development. Pharmaceutical Regulatory Affairs: Principles and Practices begins with a detailed overview of the drug development life cycle, from initial discovery and preclinical research to clinical trials and market approval, addressing scientific, regulatory, and ethical considerations at each stage. The book covers the evolution of global trade agreements like the General Agreement on Tariff and Trades (GATT) and the World Trade Organization’s (WTO) impact on pharmaceuticals, highlighting issues surrounding pharmaceutical patents and intellectual property rights. It discusses the importance of the Scale-Up and Post-Approval Changes (SUPAC) guidelines in ensuring quality and consistency in drug manufacturing post-approval and examines the World Health Organization's (WHO) guidelines on technology development and transfer. The fundamentals of regulatory affairs are covered, emphasizing the roles and responsibilities of regulatory professionals. The book provides an in-depth look at regulatory frameworks of major agencies worldwide, including the Central Drugs Standard Control Organization (CDSCO) in India, the Food and Drug Administration (FDA) in the US, the European Medicines Agency (EMA) in the EU, the Therapeutic Goods Administration (TGA) in Australia, the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, Health Canada, and regulatory authorities in emerging markets. It also addresses the international regulatory landscape for medical devices and reviews foundational pharmaceutical regulations. Additionally, the text explores regulatory guidelines for clinical testing, including the roles and responsibilities under pharmaceutical legislation, principles of bioethics and biosafety, the digital transformation in clinical trials, and the critical role of pharmacovigilance. The book concludes with an examination of the global regulatory scenario for pharmaceutical excipients, providing a detailed roadmap through the complexities of drug development, regulatory compliance, and global standards. This book is valuable for professionals, researchers, and students of pharmaceutical sciences.